State-of-the-Art and Future Directions in Structural Proteomics
Molecular & Cellular Proteomics · 2025
DOI: 10.1016/j.mcpro.2025.101065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Lotta J Happonen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection Medicine, Department of Clinical Sciences Lund, Faculty of Medicine and Science for Life Laboratory, Lund University, Lund, Swe…. Hauptthemen laut MEDLINE: Proteomics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 372 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Biocenter Finland, Sigrid Juséliuksen Säätiö.
Abstract (Originalsprache)
Structural proteomics has undergone a profound transformation, driven by the convergence of advanced experimental methodologies and computational innovations. Cutting-edge mass spectrometry (MS)-based approaches, including cross-linking MS (XL-MS), hydrogen-deuterium exchange MS (HDX-MS), and limited proteolysis MS (LiP-MS), now enable unprecedented insights into protein topology, conformational dynamics, and protein-protein interactions. These methods, complemented by affinity purification (AP), co-immunoprecipitation (co-IP), proximity labeling (PL), and spatial proteomics techniques, have expanded our ability to characterize the structural proteome at a systems-wide scale. Integration with electron cryo-microscopy (cryo-EM), cryo-electron tomography (cryo-ET), nuclear magnetic resonance (NMR) spectroscopy, X-ray crystallography, and small-angle X-ray/neutron scattering (SAXS/SANS) methods has further driven the field of integrative structural biology. These methods, in conjunction with AI-driven predictive models such as AlphaFold and RoseTTAFold, enable the high-resolution modeling of protein complexes and dynamic assemblies, bridging the gap between static structures and real-time conformational changes. This review explores the current state-of-the-art in structural proteomics, with a focus on methodological advances and the integration of XL-MS, HDX-MS, and LiP-MS with methods in structural biology. We further discuss the application of structural proteomics in deciphering disease mechanisms, identifying therapeutic targets, and guiding drug discovery, with these techniques poised to revolutionize precision medicine. Future directions emphasize fully integrative, multimodal approaches that unify experimental and computational paradigms, fostering a holistic understanding of the human proteome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infection Medicine, Department of Clinical Sciences Lund, Faculty of Medicine and Science for Life Laboratory, Lund University, Lund, Sweden. Electronic address: lotta.happonen@med.lu.se.
- Institute of Biotechnology, HiLIFE, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: markku.varjosalo@helsinki.fi.
Förderung
- Vetenskapsrådet
- Biocenter Finland
- Sigrid Juséliuksen Säätiö
- Research Council of Finland
- Helsinki Institute of Life Science, Helsingin Yliopisto
- Kungliga Fysiografiska Sällskapet i Lund
Zitieren
APA
Happonen, L. J., & Varjosalo, M. (2025). State-of-the-Art and Future Directions in Structural Proteomics. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2025.101065
Vancouver
Happonen LJ, Varjosalo M. State-of-the-Art and Future Directions in Structural Proteomics. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2025.101065
BibTeX
@article{Happonen2025,
author = {Happonen, Lotta J and Varjosalo, Markku},
title = {State-of-the-Art and Future Directions in Structural Proteomics},
journal = {Molecular & Cellular Proteomics},
year = {2025},
doi = {10.1016/j.mcpro.2025.101065}
}
EUVIMED